Generics
Emmaus Life Sciences names new chief executive officer
24 July 2024 - Sickle cell disease treatment specialist Emmaus Life Sciences Inc (OTCMarkets: EMMA) announced on Tuesday the appointment of Willis C Lee as its new chief executive officer.Lee was prev...
Sun Pharma finalises Taro acquisition
24 June 2024 - Indian pharmaceutical company Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715) confirmed on Monday that it has completed its merger with Taro Pharmaceutical Industries...
Sun Pharmaceutical announces results from Phase one, multiple ascending-dose study of GL0034 (Utreglutide) at 84th ADA
24 June 2024 - Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715), an India-based, global specialty generics company with presence in Innovativ...
Biocon seeking partner to test semaglutide generics in China
20 June 2024 - Indian biopharmaceutical company Biocon Limited (NSE:BIOCON) is seeking a partner to test generic versions of Novo Nordisk's (CPH:NOVO-B) diabetes drug Ozempic and weight loss trea...
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
16 April 2024 - Pharmaceutical company Amneal Pharmaceuticals Inc (Nasdaq: AMRX) announced on Tuesday that it has introduced PEMRYDI RTU, the inaugural ready-to-use version of pemetrexed for injection...
ANI Pharmaceuticals launches generic Baclofen Oral Suspension
9 April 2024 - Biopharmaceutical company ANI Pharmaceuticals Inc (Nasdaq:ANIP) announced on Tuesday the launch of Baclofen Oral Suspension, a generic alternative to Fleqsuvy.Baclofen Oral Suspension i...